Skip to main content
Erschienen in: Child's Nervous System 7/2019

07.05.2019 | Original Article

Prediction of calcification tendency in pediatric cystic adamantinomatous craniopharyngioma by using inflammatory markers, hormone markers, and radiological appearances

verfasst von: Ming Chen, Zhang Zhang, Min Yang, Shi-ting Li

Erschienen in: Child's Nervous System | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare the different levels of inflammatory markers, hormone markers, and radiological appearances between PCACP with and without calcification so as to explore the relationships between these markers and calcification.

Methods

The inflammatory markers, hormone markers, and radiological appearances were compared not only between PCACP with and without calcification, but also among its different forms of calcification. The receiver operating characteristic (ROC) curve was performed to evaluate the diagnostic significance of all markers between these groups.

Results

It was showed that the white blood cell (WBC) count, neutrophil count, monocyte count, prognostic nutritional index (PNI), prolactin (PRL), and T1WI signal of cysts were higher in PCACP with calcification than in PCACP without calcification. The neutrophil count was significantly higher in PCACP with eggshell calcification than in other groups. The PCACP with mixed calcification had the highest PRL level in all kinds of PCACP with calcification. Only the area under curve (AUC) values of neutrophil count and PRL level were greater than 0.8.

Conclusion

It is found that inflammation and hormone are related to PCACP’s calcification. High neutrophil count and PRL level may indicate possible calcification tendency in PCACP. Improved intracystic therapies based on these results may help to inhibit the formation of calcification in PCACP in future.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Larkin SJ, Ansorge O (2013) Pathology and pathogenesis of craniopharyngiomas. Pituitary. 16(1):9–17CrossRefPubMed Larkin SJ, Ansorge O (2013) Pathology and pathogenesis of craniopharyngiomas. Pituitary. 16(1):9–17CrossRefPubMed
2.
Zurück zum Zitat Martinez-Barbera JP, Buslei R (2015) Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models. J Pediatr Endocrinol Metab 28(1–2):7–17PubMed Martinez-Barbera JP, Buslei R (2015) Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models. J Pediatr Endocrinol Metab 28(1–2):7–17PubMed
3.
Zurück zum Zitat Prabhu VC, Brown HG (2005) The pathogenesis of craniopharyngiomas. Childs Nerv Syst 21(8–9):622–627CrossRefPubMed Prabhu VC, Brown HG (2005) The pathogenesis of craniopharyngiomas. Childs Nerv Syst 21(8–9):622–627CrossRefPubMed
4.
Zurück zum Zitat Zada G, Lin N, Ojerholm E, Ramkissoon S, Laws ER (2010) Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships. Neurosurg Focus 28(4):E4CrossRefPubMed Zada G, Lin N, Ojerholm E, Ramkissoon S, Laws ER (2010) Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships. Neurosurg Focus 28(4):E4CrossRefPubMed
5.
Zurück zum Zitat Bartels U, Laperriere N, Bouffet E, Drake J (2012) Intracystic therapies for cystic craniopharyngioma in childhood. Front Endocrinol (Lausanne) 3:39CrossRef Bartels U, Laperriere N, Bouffet E, Drake J (2012) Intracystic therapies for cystic craniopharyngioma in childhood. Front Endocrinol (Lausanne) 3:39CrossRef
7.
Zurück zum Zitat Cavalheiro S, Di Rocco C, Valenzuela S et al (2010) Craniopharyngiomas: intratumoral chemotherapy with interferon-alpha: a multicenter preliminary study with 60 cases. Neurosurg Focus 28(4):E12CrossRefPubMed Cavalheiro S, Di Rocco C, Valenzuela S et al (2010) Craniopharyngiomas: intratumoral chemotherapy with interferon-alpha: a multicenter preliminary study with 60 cases. Neurosurg Focus 28(4):E12CrossRefPubMed
8.
Zurück zum Zitat Kilday JP, Caldarelli M, Massimi L, Chen RHH, Lee YY, Liang ML, Parkes J, Naiker T, van Veelen ML, Michiels E, Mallucci C, Pettorini B, Meijer L, Dorfer C, Czech T, Diezi M, Schouten-van Meeteren AYN, Holm S, Gustavsson B, Benesch M, Müller HL, Hoffmann A, Rutkowski S, Flitsch J, Escherich G, Grotzer M, Spoudeas HA, Azquikina K, Capra M, Jiménez-Guerra R, MacDonald P, Johnston DL, Dvir R, Constantini S, Kuo MF, Yang SH, Bartels U (2017) Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN. Neuro-Oncology 19(10):1398–1407CrossRefPubMedPubMedCentral Kilday JP, Caldarelli M, Massimi L, Chen RHH, Lee YY, Liang ML, Parkes J, Naiker T, van Veelen ML, Michiels E, Mallucci C, Pettorini B, Meijer L, Dorfer C, Czech T, Diezi M, Schouten-van Meeteren AYN, Holm S, Gustavsson B, Benesch M, Müller HL, Hoffmann A, Rutkowski S, Flitsch J, Escherich G, Grotzer M, Spoudeas HA, Azquikina K, Capra M, Jiménez-Guerra R, MacDonald P, Johnston DL, Dvir R, Constantini S, Kuo MF, Yang SH, Bartels U (2017) Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN. Neuro-Oncology 19(10):1398–1407CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Steinbok P, Hukin J (2010) Intracystic treatments for craniopharyngioma. Neurosurg Focus 28(4):E13CrossRefPubMed Steinbok P, Hukin J (2010) Intracystic treatments for craniopharyngioma. Neurosurg Focus 28(4):E13CrossRefPubMed
10.
Zurück zum Zitat Zheng J, Fang Y, Cai BW et al Intracystic bleomycin for cystic craniopharyngiomas in children. Cochrane Database Syst Rev 2014(9):D8890 Zheng J, Fang Y, Cai BW et al Intracystic bleomycin for cystic craniopharyngiomas in children. Cochrane Database Syst Rev 2014(9):D8890
11.
Zurück zum Zitat Pan J, Qi S, Liu Y, Lu Y, Peng J, Zhang XA, Xu YK, Huang GL, Fan J (2016) Growth patterns of craniopharyngiomas: clinical analysis of 226 patients. J Neurosurg Pediatr 17(4):418–433CrossRefPubMed Pan J, Qi S, Liu Y, Lu Y, Peng J, Zhang XA, Xu YK, Huang GL, Fan J (2016) Growth patterns of craniopharyngiomas: clinical analysis of 226 patients. J Neurosurg Pediatr 17(4):418–433CrossRefPubMed
12.
Zurück zum Zitat Pettorini BL, Inzitari R, Massimi L, Tamburrini G, Caldarelli M, Fanali C, Cabras T, Messana I, Castagnola M, di Rocco C (2010) The role of inflammation in the genesis of the cystic component of craniopharyngiomas. Childs Nerv Syst 26(12):1779–1784CrossRefPubMed Pettorini BL, Inzitari R, Massimi L, Tamburrini G, Caldarelli M, Fanali C, Cabras T, Messana I, Castagnola M, di Rocco C (2010) The role of inflammation in the genesis of the cystic component of craniopharyngiomas. Childs Nerv Syst 26(12):1779–1784CrossRefPubMed
14.
Zurück zum Zitat Kim KH, Yavel RM, Gross VL, Brody N (2004) Intralesional interferon alpha-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: revisited. Dermatol Surg 30(1):116–120PubMed Kim KH, Yavel RM, Gross VL, Brody N (2004) Intralesional interferon alpha-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: revisited. Dermatol Surg 30(1):116–120PubMed
15.
Zurück zum Zitat Edwards L, Berman B, Rapini RP, Whiting DA, Tyring S, Greenway HT Jr, Eyre SP, Tanner DJ, Taylor EL, Peets E (1992) Treatment of cutaneous squamous cell carcinomas by intralesional interferon alfa-2b therapy. Arch Dermatol 128(11):1486–1489CrossRefPubMed Edwards L, Berman B, Rapini RP, Whiting DA, Tyring S, Greenway HT Jr, Eyre SP, Tanner DJ, Taylor EL, Peets E (1992) Treatment of cutaneous squamous cell carcinomas by intralesional interferon alfa-2b therapy. Arch Dermatol 128(11):1486–1489CrossRefPubMed
16.
Zurück zum Zitat Shin DM, Khuri FR, Murphy B, Garden AS, Clayman G, Francisco M, Liu D, Glisson BS, Ginsberg L, Papadimitrakopoulou V, Myers J, Morrison W, Gillenwater A, Ang KK, Lippman SM, Goepfert H, Hong WK (2001) Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial. J Clin Oncol 19(12):3010–3017CrossRefPubMed Shin DM, Khuri FR, Murphy B, Garden AS, Clayman G, Francisco M, Liu D, Glisson BS, Ginsberg L, Papadimitrakopoulou V, Myers J, Morrison W, Gillenwater A, Ang KK, Lippman SM, Goepfert H, Hong WK (2001) Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial. J Clin Oncol 19(12):3010–3017CrossRefPubMed
17.
Zurück zum Zitat Peng J, Qi S, Pan J, Zhang X, Huang G, Li D (2016) Preliminary study on composition and microstructure of calcification in Craniopharyngiomas. J Craniofac Surg 27(4):e409–e413CrossRefPubMedPubMedCentral Peng J, Qi S, Pan J, Zhang X, Huang G, Li D (2016) Preliminary study on composition and microstructure of calcification in Craniopharyngiomas. J Craniofac Surg 27(4):e409–e413CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Massimi L, Martelli C, Caldarelli M, Castagnola M, Desiderio C (2017) Proteomics in pediatric cystic craniopharyngioma. Brain Pathol 27(3):370–376CrossRefPubMed Massimi L, Martelli C, Caldarelli M, Castagnola M, Desiderio C (2017) Proteomics in pediatric cystic craniopharyngioma. Brain Pathol 27(3):370–376CrossRefPubMed
19.
Zurück zum Zitat Donson AM, Apps J, Griesinger AM, Amani V, Witt DA, Anderson RCE, Niazi TN, Grant G, Souweidane M, Johnston JM, Jackson EM, Kleinschmidt-DeMasters B, Handler MH, Tan AC, Gore L, Virasami A, Gonzalez-Meljem JM, Jacques TS, Martinez-Barbera JP, Foreman NK, Hankinson TC, Advancing Treatment for Pediatric Craniopharyngioma Consortium (2017) Molecular analyses reveal inflammatory mediators in the solid component and cyst fluid of human Adamantinomatous Craniopharyngioma. J Neuropathol Exp Neurol 76(9):779–788CrossRefPubMedPubMedCentral Donson AM, Apps J, Griesinger AM, Amani V, Witt DA, Anderson RCE, Niazi TN, Grant G, Souweidane M, Johnston JM, Jackson EM, Kleinschmidt-DeMasters B, Handler MH, Tan AC, Gore L, Virasami A, Gonzalez-Meljem JM, Jacques TS, Martinez-Barbera JP, Foreman NK, Hankinson TC, Advancing Treatment for Pediatric Craniopharyngioma Consortium (2017) Molecular analyses reveal inflammatory mediators in the solid component and cyst fluid of human Adamantinomatous Craniopharyngioma. J Neuropathol Exp Neurol 76(9):779–788CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Martelli C, Iavarone F, Vincenzoni F, Rossetti DV, D'Angelo L, Tamburrini G, Caldarelli M, di Rocco C, Messana I, Castagnola M, Desiderio C (2014) Proteomic characterization of pediatric craniopharyngioma intracystic fluid by LC-MS top-down/bottom-up integrated approaches. Electrophoresis. 35(15):2172–2183PubMed Martelli C, Iavarone F, Vincenzoni F, Rossetti DV, D'Angelo L, Tamburrini G, Caldarelli M, di Rocco C, Messana I, Castagnola M, Desiderio C (2014) Proteomic characterization of pediatric craniopharyngioma intracystic fluid by LC-MS top-down/bottom-up integrated approaches. Electrophoresis. 35(15):2172–2183PubMed
21.
Zurück zum Zitat Chen M, Zheng SH, Yang M, Chen ZH, Li ST (2018) The diagnostic value of preoperative inflammatory markers in craniopharyngioma: a multicenter cohort study. J Neuro-Oncol 138(1):113–122CrossRef Chen M, Zheng SH, Yang M, Chen ZH, Li ST (2018) The diagnostic value of preoperative inflammatory markers in craniopharyngioma: a multicenter cohort study. J Neuro-Oncol 138(1):113–122CrossRef
22.
Zurück zum Zitat Mori M, Takeshima H, Kuratsu J (2004) Expression of interleukin-6 in human craniopharyngiomas: a possible inducer of tumor-associated inflammation. Int J Mol Med 14(4):505–509PubMed Mori M, Takeshima H, Kuratsu J (2004) Expression of interleukin-6 in human craniopharyngiomas: a possible inducer of tumor-associated inflammation. Int J Mol Med 14(4):505–509PubMed
23.
Zurück zum Zitat Liu Y, Wang CH, Li DL, Zhang SC, Peng YP, Peng JX, Song Y, Qi ST, Pan J (2016) TREM-1 expression in craniopharyngioma and Rathke's cleft cyst: its possible implication for controversial pathology. Oncotarget. 7(31):50564–50574PubMedPubMedCentral Liu Y, Wang CH, Li DL, Zhang SC, Peng YP, Peng JX, Song Y, Qi ST, Pan J (2016) TREM-1 expression in craniopharyngioma and Rathke's cleft cyst: its possible implication for controversial pathology. Oncotarget. 7(31):50564–50574PubMedPubMedCentral
24.
Zurück zum Zitat Singh S, Sadanandam A, Nannuru KC, Varney ML, Mayer-Ezell R, Bond R, Singh RK (2009) Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis. Clin Cancer Res 15(7):2380–2386CrossRefPubMedPubMedCentral Singh S, Sadanandam A, Nannuru KC, Varney ML, Mayer-Ezell R, Bond R, Singh RK (2009) Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis. Clin Cancer Res 15(7):2380–2386CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Todd CM, Salter BM, Murphy DM, Watson RM, Howie KJ, Milot J, Sadeh J, Boulet LP, O'Byrne PM, Gauvreau GM (2016) The effects of a CXCR1/CXCR2 antagonist on neutrophil migration in mild atopic asthmatic subjects. Pulm Pharmacol Ther 41:34–39CrossRefPubMed Todd CM, Salter BM, Murphy DM, Watson RM, Howie KJ, Milot J, Sadeh J, Boulet LP, O'Byrne PM, Gauvreau GM (2016) The effects of a CXCR1/CXCR2 antagonist on neutrophil migration in mild atopic asthmatic subjects. Pulm Pharmacol Ther 41:34–39CrossRefPubMed
26.
Zurück zum Zitat Andoniadou CL, Gaston-Massuet C, Reddy R, Schneider RP, Blasco MA, le Tissier P, Jacques TS, Pevny LH, Dattani MT, Martinez-Barbera JP (2012) Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma. Acta Neuropathol 124(2):259–271CrossRefPubMedPubMedCentral Andoniadou CL, Gaston-Massuet C, Reddy R, Schneider RP, Blasco MA, le Tissier P, Jacques TS, Pevny LH, Dattani MT, Martinez-Barbera JP (2012) Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma. Acta Neuropathol 124(2):259–271CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Gump JM, Donson AM, Birks DK, Amani VM, Rao KK, Griesinger AM, Kleinschmidt-DeMasters BK, Johnston JM, Anderson RCE, Rosenfeld A, Handler M, Gore L, Foreman N, Hankinson TC (2015) Identification of targets for rational pharmacological therapy in childhood craniopharyngioma. Acta Neuropathol Commun 3:30CrossRefPubMedPubMedCentral Gump JM, Donson AM, Birks DK, Amani VM, Rao KK, Griesinger AM, Kleinschmidt-DeMasters BK, Johnston JM, Anderson RCE, Rosenfeld A, Handler M, Gore L, Foreman N, Hankinson TC (2015) Identification of targets for rational pharmacological therapy in childhood craniopharyngioma. Acta Neuropathol Commun 3:30CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12(3):223–226CrossRefPubMed McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12(3):223–226CrossRefPubMed
29.
Zurück zum Zitat Gu L, Li H, Chen L et al (2016) Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis. Oncotarget. 7(22):31926–31942CrossRefPubMedPubMedCentral Gu L, Li H, Chen L et al (2016) Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis. Oncotarget. 7(22):31926–31942CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Fernandez-Palomeque C, Grau A, Perello J et al (2015) Relationship between urinary level of Phytate and Valvular calcification in an elderly population: a cross-sectional study. PLoS One 10(8):e136560CrossRef Fernandez-Palomeque C, Grau A, Perello J et al (2015) Relationship between urinary level of Phytate and Valvular calcification in an elderly population: a cross-sectional study. PLoS One 10(8):e136560CrossRef
31.
Zurück zum Zitat Efe TH, Gayretli YK, Yayla C et al (2016) Calcific aortic stenosis and its correlation with a novel inflammatory marker, the lymphocyte/monocyte ratio. Rev Port Cardiol 35(11):573–578CrossRefPubMed Efe TH, Gayretli YK, Yayla C et al (2016) Calcific aortic stenosis and its correlation with a novel inflammatory marker, the lymphocyte/monocyte ratio. Rev Port Cardiol 35(11):573–578CrossRefPubMed
32.
Zurück zum Zitat Nam SH, Kang SG, Song SW (2017) The neutrophil-lymphocyte ratio is associated with coronary artery calcification in asymptomatic Korean males: a cross-sectional study. Biomed Res Int 2017:1989417PubMedPubMedCentral Nam SH, Kang SG, Song SW (2017) The neutrophil-lymphocyte ratio is associated with coronary artery calcification in asymptomatic Korean males: a cross-sectional study. Biomed Res Int 2017:1989417PubMedPubMedCentral
33.
Zurück zum Zitat Zhou S, Cai B, Zhang Y, Wang L, Liu X, Xu G (2017) The relationship between neutrophil-to-lymphocyte ratio and aortic arch calcification in ischemic stroke patients. J Stroke Cerebrovasc Dis 26(6):1228–1232CrossRefPubMed Zhou S, Cai B, Zhang Y, Wang L, Liu X, Xu G (2017) The relationship between neutrophil-to-lymphocyte ratio and aortic arch calcification in ischemic stroke patients. J Stroke Cerebrovasc Dis 26(6):1228–1232CrossRefPubMed
34.
Zurück zum Zitat Hou L, Lloyd-Jones DM, Ning H, Huffman MD, Fornage M, He K, Zhang X, Jacobs DR, Goff DC, Sidney S, Carr JJ, Liu K (2013) White blood cell count in young adulthood and coronary artery calcification in early middle age: coronary artery risk development in young adults (CARDIA) study. Eur J Epidemiol 28(9):735–742CrossRefPubMedPubMedCentral Hou L, Lloyd-Jones DM, Ning H, Huffman MD, Fornage M, He K, Zhang X, Jacobs DR, Goff DC, Sidney S, Carr JJ, Liu K (2013) White blood cell count in young adulthood and coronary artery calcification in early middle age: coronary artery risk development in young adults (CARDIA) study. Eur J Epidemiol 28(9):735–742CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Zhou J, Zhang C, Pan J, Chen L, Qi ST (2017) Interleukin6 induces an epithelialmesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration. Mol Med Rep 15(6):4123–4131CrossRefPubMedPubMedCentral Zhou J, Zhang C, Pan J, Chen L, Qi ST (2017) Interleukin6 induces an epithelialmesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration. Mol Med Rep 15(6):4123–4131CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Zhou W, Ke SQ, Huang Z, Flavahan W, Fang X, Paul J, Wu L, Sloan AE, McLendon RE, Li X, Rich JN, Bao S (2015) Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nat Cell Biol 17(2):170–182CrossRefPubMedPubMedCentral Zhou W, Ke SQ, Huang Z, Flavahan W, Fang X, Paul J, Wu L, Sloan AE, McLendon RE, Li X, Rich JN, Bao S (2015) Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nat Cell Biol 17(2):170–182CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Chen M, Zheng SH, Liu Y, Shi J, Qi ST (2016) Periostin activates pathways involved in epithelial-mesenchymal transition in adamantinomatous craniopharyngioma. J Neurol Sci 360:49–54CrossRefPubMed Chen M, Zheng SH, Liu Y, Shi J, Qi ST (2016) Periostin activates pathways involved in epithelial-mesenchymal transition in adamantinomatous craniopharyngioma. J Neurol Sci 360:49–54CrossRefPubMed
40.
Zurück zum Zitat Seriwatanachai D, Krishnamra N, van Leeuwen JP (2009) Evidence for direct effects of prolactin on human osteoblasts: inhibition of cell growth and mineralization. J Cell Biochem 107(4):677–685CrossRefPubMed Seriwatanachai D, Krishnamra N, van Leeuwen JP (2009) Evidence for direct effects of prolactin on human osteoblasts: inhibition of cell growth and mineralization. J Cell Biochem 107(4):677–685CrossRefPubMed
41.
Zurück zum Zitat Charoenphandhu N, Teerapornpuntakit J, Methawasin M, Wongdee K, Thongchote K, Krishnamra N (2008) Prolactin decreases expression of Runx2, osteoprotegerin, and RANKL in primary osteoblasts derived from tibiae of adult female rats. Can J Physiol Pharmacol 86(5):240–248CrossRefPubMed Charoenphandhu N, Teerapornpuntakit J, Methawasin M, Wongdee K, Thongchote K, Krishnamra N (2008) Prolactin decreases expression of Runx2, osteoprotegerin, and RANKL in primary osteoblasts derived from tibiae of adult female rats. Can J Physiol Pharmacol 86(5):240–248CrossRefPubMed
42.
Zurück zum Zitat Kasantikul V, Maneesri S, Lerdlum S, Panichabhongse V (1995) Calcified cystic pituitary prolactinoma. J Med Assoc Thail 78(9):497–501 Kasantikul V, Maneesri S, Lerdlum S, Panichabhongse V (1995) Calcified cystic pituitary prolactinoma. J Med Assoc Thail 78(9):497–501
43.
Zurück zum Zitat Horiuchi T, Tanaka Y, Kobayashi S, Yokoh A, Unoki T (1996) Total capsular calcification in a prolactinoma--case report. Neurol Med Chir (Tokyo) 36(10):729–732CrossRef Horiuchi T, Tanaka Y, Kobayashi S, Yokoh A, Unoki T (1996) Total capsular calcification in a prolactinoma--case report. Neurol Med Chir (Tokyo) 36(10):729–732CrossRef
44.
Zurück zum Zitat Ogiwara T, Nagm A, Yamamoto Y, Hasegawa T, Nishikawa A, Hongo K (2017) Clinical characteristics of pituitary adenomas with radiological calcification. Acta Neurochir 159(11):2187–2192CrossRefPubMed Ogiwara T, Nagm A, Yamamoto Y, Hasegawa T, Nishikawa A, Hongo K (2017) Clinical characteristics of pituitary adenomas with radiological calcification. Acta Neurochir 159(11):2187–2192CrossRefPubMed
45.
Zurück zum Zitat Bakhtiar Y, Arita K, Hirano H et al (2010) Prolactin-producing pituitary adenoma with abundant spherical amyloid deposition masquerading as extensive calcification. Neurol Med Chir (Tokyo) 50(11):1023–1026CrossRef Bakhtiar Y, Arita K, Hirano H et al (2010) Prolactin-producing pituitary adenoma with abundant spherical amyloid deposition masquerading as extensive calcification. Neurol Med Chir (Tokyo) 50(11):1023–1026CrossRef
Metadaten
Titel
Prediction of calcification tendency in pediatric cystic adamantinomatous craniopharyngioma by using inflammatory markers, hormone markers, and radiological appearances
verfasst von
Ming Chen
Zhang Zhang
Min Yang
Shi-ting Li
Publikationsdatum
07.05.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Child's Nervous System / Ausgabe 7/2019
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-019-04178-0

Weitere Artikel der Ausgabe 7/2019

Child's Nervous System 7/2019 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.